Cargando…

The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patients

BACKGROUND: Mammography and ultrasound are the gold standard imaging techniques for preoperative assessment and for monitoring the efficacy of neoadjuvant chemotherapy in breast cancer. Maximum accuracy in predicting pathological tumor size non-invasively is critical for individualized therapy and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Stein, Roland Gregor, Wollschläger, Daniel, Kreienberg, Rolf, Janni, Wolfgang, Wischnewsky, Manfred, Diessner, Joachim, Stüber, Tanja, Bartmann, Catharina, Krockenberger, Mathias, Wischhusen, Jörg, Wöckel, Achim, Blettner, Maria, Schwentner, Lukas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943017/
https://www.ncbi.nlm.nih.gov/pubmed/27411945
http://dx.doi.org/10.1186/s12885-016-2426-7
_version_ 1782442520331943936
author Stein, Roland Gregor
Wollschläger, Daniel
Kreienberg, Rolf
Janni, Wolfgang
Wischnewsky, Manfred
Diessner, Joachim
Stüber, Tanja
Bartmann, Catharina
Krockenberger, Mathias
Wischhusen, Jörg
Wöckel, Achim
Blettner, Maria
Schwentner, Lukas
author_facet Stein, Roland Gregor
Wollschläger, Daniel
Kreienberg, Rolf
Janni, Wolfgang
Wischnewsky, Manfred
Diessner, Joachim
Stüber, Tanja
Bartmann, Catharina
Krockenberger, Mathias
Wischhusen, Jörg
Wöckel, Achim
Blettner, Maria
Schwentner, Lukas
author_sort Stein, Roland Gregor
collection PubMed
description BACKGROUND: Mammography and ultrasound are the gold standard imaging techniques for preoperative assessment and for monitoring the efficacy of neoadjuvant chemotherapy in breast cancer. Maximum accuracy in predicting pathological tumor size non-invasively is critical for individualized therapy and surgical planning. We therefore aimed to assess the accuracy of tumor size measurement by ultrasound and mammography in a multicentered health services research study. METHODS: We retrospectively analyzed data from 6543 patients with unifocal, unilateral primary breast cancer. The maximum tumor diameter was measured by ultrasound and/or mammographic imaging. All measurements were compared to final tumor diameter determined by postoperative histopathological examination. We compared the precision of each imaging method across different patient subgroups as well as the method-specific accuracy in each patient subgroup. RESULTS: Overall, the correlation with histology was 0.61 for mammography and 0.60 for ultrasound. Both correlations were higher in pT2 cancers than in pT1 and pT3. Ultrasound as well as mammography revealed a significantly higher correlation with histology in invasive ductal compared to lobular cancers (p < 0.01). For invasive lobular cancers, the mammography showed better correlation with histology than ultrasound (p = 0.01), whereas there was no such advantage for invasive ductal cancers. Ultrasound was significantly superior for HR negative cancers (p < 0.001). HER2/neu positive cancers were also more precisely assessed by ultrasound (p < 0.001). The size of HER2/neu negative cancers could be more accurately predicted by mammography (p < 0.001). CONCLUSION: This multicentered health services research approach demonstrates that predicting tumor size by mammography and ultrasound provides accurate results. Biological tumor features do, however, affect the diagnostic precision.
format Online
Article
Text
id pubmed-4943017
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49430172016-07-14 The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patients Stein, Roland Gregor Wollschläger, Daniel Kreienberg, Rolf Janni, Wolfgang Wischnewsky, Manfred Diessner, Joachim Stüber, Tanja Bartmann, Catharina Krockenberger, Mathias Wischhusen, Jörg Wöckel, Achim Blettner, Maria Schwentner, Lukas BMC Cancer Research Article BACKGROUND: Mammography and ultrasound are the gold standard imaging techniques for preoperative assessment and for monitoring the efficacy of neoadjuvant chemotherapy in breast cancer. Maximum accuracy in predicting pathological tumor size non-invasively is critical for individualized therapy and surgical planning. We therefore aimed to assess the accuracy of tumor size measurement by ultrasound and mammography in a multicentered health services research study. METHODS: We retrospectively analyzed data from 6543 patients with unifocal, unilateral primary breast cancer. The maximum tumor diameter was measured by ultrasound and/or mammographic imaging. All measurements were compared to final tumor diameter determined by postoperative histopathological examination. We compared the precision of each imaging method across different patient subgroups as well as the method-specific accuracy in each patient subgroup. RESULTS: Overall, the correlation with histology was 0.61 for mammography and 0.60 for ultrasound. Both correlations were higher in pT2 cancers than in pT1 and pT3. Ultrasound as well as mammography revealed a significantly higher correlation with histology in invasive ductal compared to lobular cancers (p < 0.01). For invasive lobular cancers, the mammography showed better correlation with histology than ultrasound (p = 0.01), whereas there was no such advantage for invasive ductal cancers. Ultrasound was significantly superior for HR negative cancers (p < 0.001). HER2/neu positive cancers were also more precisely assessed by ultrasound (p < 0.001). The size of HER2/neu negative cancers could be more accurately predicted by mammography (p < 0.001). CONCLUSION: This multicentered health services research approach demonstrates that predicting tumor size by mammography and ultrasound provides accurate results. Biological tumor features do, however, affect the diagnostic precision. BioMed Central 2016-07-13 /pmc/articles/PMC4943017/ /pubmed/27411945 http://dx.doi.org/10.1186/s12885-016-2426-7 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Stein, Roland Gregor
Wollschläger, Daniel
Kreienberg, Rolf
Janni, Wolfgang
Wischnewsky, Manfred
Diessner, Joachim
Stüber, Tanja
Bartmann, Catharina
Krockenberger, Mathias
Wischhusen, Jörg
Wöckel, Achim
Blettner, Maria
Schwentner, Lukas
The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patients
title The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patients
title_full The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patients
title_fullStr The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patients
title_full_unstemmed The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patients
title_short The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patients
title_sort impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943017/
https://www.ncbi.nlm.nih.gov/pubmed/27411945
http://dx.doi.org/10.1186/s12885-016-2426-7
work_keys_str_mv AT steinrolandgregor theimpactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT wollschlagerdaniel theimpactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT kreienbergrolf theimpactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT janniwolfgang theimpactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT wischnewskymanfred theimpactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT diessnerjoachim theimpactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT stubertanja theimpactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT bartmanncatharina theimpactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT krockenbergermathias theimpactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT wischhusenjorg theimpactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT wockelachim theimpactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT blettnermaria theimpactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT schwentnerlukas theimpactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT theimpactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT steinrolandgregor impactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT wollschlagerdaniel impactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT kreienbergrolf impactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT janniwolfgang impactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT wischnewskymanfred impactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT diessnerjoachim impactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT stubertanja impactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT bartmanncatharina impactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT krockenbergermathias impactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT wischhusenjorg impactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT wockelachim impactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT blettnermaria impactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT schwentnerlukas impactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients
AT impactofbreastcancerbiologicalsubtypingontumorsizeassessmentbyultrasoundandmammographyaretrospectivemulticentercohortstudyof6543primarybreastcancerpatients